LIVE MARKET DESK
Newswire briefs, filings, valuation notes, options flow and technical charts — organized as a market front page instead of a raw archive.
U.S. stocks opened higher but moved lower in early trading. The S&P 500 turned down 0.5% after rising 0.7%, while the Dow Jones Industrial Average fell 0.4% after gaining 0.4%.\n\nThe Nasdaq dropped about 0.5% after rising 1.3%. The Philadelphia Semiconductor…
Tickers appearing most often in the latest published notes.
U.S. stocks opened higher but moved lower in early trading. The S&P 500 turned down 0.5% after rising 0.7%, while the Dow Jones Industrial Average fell 0.4% after gaining 0.4%.\n\nThe Nasdaq dropped about 0.5% after rising 1.3%. The Philadelphia Semiconductor…
Chevron CEO Mike Wirth told investors on an earnings call that Chevron had been loading crude oil this week at the CPC terminal on Russia’s Black Sea coast. “To ensure the continued operation of the pipeline, we are working closely with the governments of coun…
Vale Base Metals CEO Shaun Usmar said the company’s future copper production could exceed its target of doubling output to 700,000 metric tons by 2035. During an earnings call with investors, Usmar stopped short of promising that Vale would reach the target ah…
Nick Timiraos, known as the “Fed whisperer,” said the three Federal Reserve presidents who supported a rate hike at the July FOMC meeting and dissented from the decision arguably provided a fuller explanation of their reasoning than the Fed majority did in Wed…
In late European trading on Friday, July 31, ICE UK natural gas futures rose 1.24% to 144.24 pence per therm. The contract had gained 35.98% for July, continuing its overall upward trend. It reached 157.560 pence at the start of U.S. stock trading on July 24 a…
Vale said it will decide in the third quarter between making a dividend payment and conducting share buybacks. The source page lists a publication timestamp of July 31, 2026, at 14:37:41 UTC. The source does not provide a reliable specific event date.
This summer has been challenging for Orlando, Florida, the “Theme Park Capital” of the United States. Hotel occupancy in the Orlando area declined in June, while revenue per available room, or RevPAR, fell 4.4% overall. The number of passengers arriving at Orl…
AbbVie reported second-quarter net revenue of $16.99 billion, compared with estimates of $16.77 billion. Second-quarter adjusted earnings per share were $3.65, versus estimates of $3.61. AbbVie expects full-year adjusted earnings per share of $13.87 to $14.07,…
Latest close on July 31, 2026: $318.90 (-1.0% on the latest daily bar). HMA21 / HMA55: $321.51 / $322.99. 200DMA: $305.85. Relative volume: 0.21x the 20-day average. Latest comparable filing period: 2026 Q2 ending 2026-06-30; filed 2026-07-28. Comparable growt…
Latest close on July 31, 2026: $855.95 (-1.1% on the latest daily bar). HMA21 / HMA55: $873.23 / $847.54. 200DMA: $835.87. Relative volume: 0.30x the 20-day average. Latest comparable filing period: 2026 FY ending 2026-03-31; filed 2026-05-08. Comparable growt…
Latest close on July 31, 2026: $348.79 (+4.5% on the latest daily bar). HMA21 / HMA55: $325.12 / $337.94. 200DMA: $326.24. Relative volume: 0.57x the 20-day average. Latest comparable filing period: 2026 Q2 ending 2026-06-30; filed 2026-07-23. Comparable growt…
Linde, one of the world’s largest industrial-gas companies, said Friday that it will invest approximately $1 billion to expand its industrial-gas facilities in Phoenix, Arizona, supporting a new capacity expansion by a leading global semiconductor manufacturer…
Rosenblatt Securities raised its price target for Apple to $300 from $276, CLS reported July 31.
Monness Crespi Hardt raised its price target for Amazon stock to $330 from $315, according to CLS. The source does not provide a reliable year for the July 31 event date.
Jefferies lowered its price target for Apple to $285.56 from $308.92, CLS reported on July 31.
Bernstein lowered its price target for Walmart to $142 from $145, according to CLS.
Novo Nordisk shares fell more than 8% in premarket trading after the company said its anti-inflammatory drug Ziltivekimab showed no significant difference from placebo in reducing the risk of major adverse cardiovascular events, or MACE.